Patents Assigned to Target Technologies, Inc.
  • Patent number: 11090309
    Abstract: The present invention is related to compositions and methods for treating platelet-related diseases.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: August 17, 2021
    Assignees: TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Molecular Targeting Technologies. Inc.
    Inventors: Parkson L-G Chong, Lawrence E. Goldfinger, Koon Y. Pak, Brian D. Gray
  • Publication number: 20170042633
    Abstract: A preoperative tumor marking may be used to assist physicians in the removal of tumor tissue by clearly defining the margins of the tumor. An imaging technique, such as mammography, may be employed to visualize the tumor. The visualized tumor may be marked with a polymer, either directly or indirectly. The polymer may be liquid at room temperature and harden at body temperature, making the tumor palpable, but not changing the tumor's cellular and physical state. The polymer may also include a coloring agent that may aid in visualizing the lesion. This will assist a surgeon during excision by allowing him/her to both feel and see the tumor and remove enough of the tissue surrounding the tumor to greatly reduce the need for a second surgical procedure due to a failure to remove all tumor tissue during an initial surgery.
    Type: Application
    Filed: August 9, 2016
    Publication date: February 16, 2017
    Applicant: Malignext Targeting Technologies, Inc.
    Inventors: Jarrett LeClaire, Jamie Khaw
  • Patent number: 9388193
    Abstract: Dipicolylamine compounds of Formula (I) set forth herein. Also disclosed are pharmaceutical compositions containing metal ions and these compounds. Further disclosed is a method for treating a condition associated with cells containing inside-out phosphatidylserine, with these compounds.
    Type: Grant
    Filed: May 14, 2015
    Date of Patent: July 12, 2016
    Assignees: National Health Research Institutes, Molecular Targeting Technologies, Inc.
    Inventors: Chiung-Tong Chen, Kak-Shan Shia, Chien-Huang Wu, Lun-Kelvin Tsou, Yu-Sheng Chao
  • Patent number: 9211349
    Abstract: Embodiments provide dual modality probes for imaging phosphatidylserine (PS) exposure and other anionic membrane surfaces. In various embodiments, the probes were constructed by utilizing a) the high selectivity of synthetic zinc (II) dipicolylamine coordination complexes (Zn-DPA) for targeting externalized PS which over-expresses in apoptotic and necrotic cells, b) a near-infrared (NIR) dye for optical imaging, and c) a widely used clinically approved radionuclide for PET (or SPECT) imaging. A variety of linking elements were incorporated into the probes between the Zn-DPA and radionuclide motif to modulate the pharmacokinetics. The in vitro and in vivo data of radiolabeled dipicolylamine probes demonstrated their utilities for imaging PS exposure with multiple imaging modalities.
    Type: Grant
    Filed: June 4, 2013
    Date of Patent: December 15, 2015
    Assignee: Molecular Targeting Technologies, Inc.
    Inventors: Brian Gray, Kai Chen, Koon Y. Pak
  • Patent number: 8273875
    Abstract: Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to novel near-infrared dyes that are photostable and resistant to quenching. The dyes belong to a novel family of squaraine rotaxanes, and they are particularly well-suited for use in biological applications. Also disclosed are methods of synthesizing the dyes and methods of using the dyes.
    Type: Grant
    Filed: November 16, 2009
    Date of Patent: September 25, 2012
    Assignees: University of Notre Dame du Lac, Molecular Targeting Technologies, Inc.
    Inventors: Bradley Smith, Arunkumar Easwaran
  • Publication number: 20110301456
    Abstract: A preoperative tumor marking may be used to assist physicians in the removal of tumor tissue by clearly defining the margins of the tumor. An imaging technique, such as mammography, may be employed to visualize the tumor. The visualized tumor may be marked with a polymer, either directly or indirectly. The polymer may be liquid at room temperature and harden at body temperature, making the tumor palpable, but not changing the tumor's cellular and physical state. The polymer may also include a coloring agent that may aid in visualizing the lesion. This will assist a surgeon during excision by allowing him/her to both feel and see the tumor and remove enough of the tissue surrounding the tumor to greatly reduce the need for a second surgical procedure due to a failure to remove all tumor tissue during an initial surgery.
    Type: Application
    Filed: June 7, 2010
    Publication date: December 8, 2011
    Applicant: Malignext Targeting Technologies, Inc.
    Inventors: Jarrett LeClaire, Jamie Khaw
  • Publication number: 20110118459
    Abstract: Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to novel near-infrared dyes that are photostable and resistant to quenching. The dyes belong to a novel family of squaraine rotaxanes, and they are particularly well-suited for use in biological applications. Also disclosed are methods of synthesizing the dyes and methods of using the dyes.
    Type: Application
    Filed: November 16, 2009
    Publication date: May 19, 2011
    Applicants: University of Notre Dame du Lac, Molecular Targeting Technologies, Inc.
    Inventors: Bradley Smith, Arunkumar Easwaran
  • Patent number: 5534914
    Abstract: A videoconferencing network for digital computer workstations that operate on a local area network (LAN) to exchange data. The network includes a signalling local area network (A-LAN), connected to a first port of a plurality of workstations, for transmitting and receiving data signals between selected ones of the workstations and a broadband local area network (B-LAN) connected to a second port of the plurality of workstations, for transmitting and receiving television signals between selected ones of these workstations. Each television signal is transmitted at a selected frequency channel so that no two transmissions interfere. A software program, stored in and operable on the computer of each workstation, generates and receives data messages, transmitted via the A-LAN, to and from the computer of another workstation, respectively.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: July 9, 1996
    Assignee: Target Technologies, Inc.
    Inventors: Daniel P. Flohr, Stuart Ross
  • Patent number: 5374952
    Abstract: A videoconferencing network for digital computer workstations that operate on a local area network (LAN) to exchange data. The network includes a signalling local area network (A-LAN), connected to a first port of a plurality of workstations, for transmitting and receiving data signals between selected ones of the workstations and a broadband local area network (B-LAN) connected to a second port of the plurality of workstations, for transmitting and receiving television signals between selected ones of these workstations. Each television signal is transmitted at a selected frequency channel so that no two transmissions interfere. A software program, stored in and operable on the computer of each workstation, generates and receives data messages, transmitted via the A-LAN, to and from the computer of another workstation, respectively.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: December 20, 1994
    Assignee: Target Technologies, Inc.
    Inventor: Daniel P. Flohr
  • Patent number: 4915718
    Abstract: In the fabrication of an ink jet nozzle structure for ink jet printing, photoform glass is initially exposed in the general configuration of the ink chambers and nozzles desired to be formed in the glass. Thin transverse lines are left unexposed across the desired transition point between the ink chamber and the nozzle, and across a transition between ink inlet and the chamber. The ink chamber is desired to be of greater depth than either the inlet area or the nozzle, so two-step acid etching is used. The nozzle and the inlet are masked, as by taping, during a portion of the acid etching and unmasked during another portion, so that the chamber (which is never masked) is etched deeper than the inlet and nozzle areas.
    Type: Grant
    Filed: September 28, 1988
    Date of Patent: April 10, 1990
    Assignee: On Target Technology, Inc.
    Inventor: Prakash D. Desai
  • Patent number: D363730
    Type: Grant
    Filed: July 18, 1994
    Date of Patent: October 31, 1995
    Assignee: Target Technologies, Inc.
    Inventors: Daniel P. Flohr, Charles Floyd